Nattokinase Market Size, Share And Trends Analysis Report, 2030

 


Nattokinase Market Growth & Trends

The global nattokinase market is expected to reach USD 40.1 million by 2030 and growing at a CAGR of 3.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. A major factor propelling the nattokinase market worldwide is the trend towards natural and functional supplements. Customers are looking for natural substitutes that have positive health impacts without unfavorable side effects due to growing cautious of synthetic ingredients. Nattokinase is a natural enzyme owing to which it is adoption is rising in supplement manufacturing. Another significant factor propelling the nattokinase market's sales is the growing customer inclination for supplements that promote general health and wellbeing.

A rising number of customers are looking for foods that offer health advantages over just basic nourishment. The demand for nattokinase has increased significantly as low-carb and gluten-free diets have become more and more popular. Many customers follow gluten-free diets for various health-related reasons, or they have been diagnosed with celiac disease. This market is expanding, and nattokinase is a great alternative to wheat flour in baking and cooking. Almond powder has also become more popular due to the ketogenic diet, which places a strong emphasis on consuming large amounts of fat and few carbohydrates. It is a mainstay in recipes that are keto-friendly due to its low carbohydrate level.

Nattokinase is being included in functional foods and beverages by the food and beverage sector. In addition to providing basic nutrition, these products are made to offer additional health benefits. the usage and market penetration of nattokinase is anticipated to increase owing to its rising incorporation into regular food products. Nattokinase is further utilized in the cosmetics business due to its possible anti-aging and skin health advantages. The enzyme is a useful component in skincare formulas owing to its capacity to promote blood flow and break blood clots, both of which can improve skin health.

Nutraceuticals application held the highest share of the market in 2023. The growing emphasis on health and wellness has driven a heightened consumer interest in natural and effective supplements to support well-being. Nutraceuticals, encompassing functional foods and dietary supplements, are increasingly favored for their perceived safety and health benefits. There is a global shift towards preventive healthcare, with consumers prioritizing measures to prevent diseases rather than merely treating them reactively. Nattokinase, renowned for its cardiovascular benefits, has thus gained prominence in the production of dietary supplements, contributing significantly to market expansion.

Nattokinase is majorly used in dietary supplements; however, its applications are expanding into other areas such as pharmaceuticals, food additives, and cosmetics. The unique properties of this enzyme make it suitable for various applications, thus broadening its market potential. In the pharmaceutical sector, nattokinase is being researched for its potential in developing novel therapeutic agents for cardiovascular diseases. Its natural origin and proven efficacy make it a key ingredient for drug development. Moreover, the increasing interest in natural health solutions among pharmaceutical companies is likely to drive further research and application of nattokinase.

The food and beverage industry is also incorporating nattokinase into functional foods and beverages. These products are designed to offer additional health benefits beyond basic nutrition. The integration of nattokinase into everyday food products is expected to increase its consumption and market penetration. In the cosmetics industry, nattokinase is being used for its potential anti-aging and skin health benefits. The enzyme's ability to improve circulation and dissolve blood clots can enhance skin health, making it a valuable ingredient in skincare formulations. Furthermore, technological advancements in the production processes of nattokinase are contributing to the market growth. Improved fermentation techniques and bioprocessing technologies have enhanced the yield and purity of nattokinase, making it more cost-effective and efficient to produce.

Major players in the nattokinase market include Japan Bio Science Laboratory Co., Ltd., Novonesis Group (MenaquinGold), Contek Life Science Co., Ltd., and others. Companies are taking various steps such as global expansion, partnerships, acquisitions & mergers, development & launch of new products, and others to gain more share of the market.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/nattokinase-market-report

Nattokinase Market Report Highlights

  • Based on application, pharmaceuticals segment is expected to grow at a CAGR of 3.6% from 2024 to 2030. The increasing prevalence of chronic diseases, notably cardiovascular conditions, has surged the demand for efficient treatments. This trend is a significant driver propelling the nattokinase market forward.
  • Asia Pacific is expected to grow at a CAGR of 3.5% from 2024 to 2030. The growing awareness regarding the significance of cardiovascular and overall health among consumers in the region is driving the market growth.

 

Nattokinase Market Segmentation

Grand View Research has segmented the global nattokinase market on the basis of application, and region.

Nattokinase Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Nutraceuticals
  • Food Additives
  • Pharmaceuticals
  • Others

Nattokinase Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
  • Europe
  • Asia Pacific
  • Central & South America
  • Middle East & Africa

List of Key Players in the Nattokinase Market

  • Japan Bio Science Laboratory Co., Ltd.
  • Novonesis Group (MenaquinGold)
  • Creative Enzymes
  • Weidan Biotechnology Co., Ltd.
  • BIO-CAT
  • Bioven Ingredients
  • Eiffel Biotech
  • Daiwa Pharmaceutical Co. Ltd.
  • Contek Life Science Co., Ltd.
  • Sungen Bioscience Co., Ltd

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/nattokinase-market-report

Comments

Popular posts from this blog

Virtual Clinical Trials Market Size Reaches USD 12.9 Billion By 2030

Industrial Refrigeration Systems Market Size, Share & Trends Report, 2030

U.S. Virtual Visits Market Size To Reach USD 105.5Bn By 2030